Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Berberine Suppresses SASP in Atherosclerosis via RXRα/PPARγ/
2026-06-15
The reference study reveals that berberine attenuates senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 signaling axis in macrophage-derived foam cells. These findings clarify a mechanistic basis for targeting chronic vascular inflammation and suggest new avenues for anti-aging cardiovascular therapy.
-
Hypoxia-Induced S100A10 Drives GBM Chemoresistance via PI3K-
2026-06-15
This study identifies S100A10 as a hypoxia-responsive gene that promotes glioblastoma (GBM) malignancy and resistance to temozolomide by activating the PI3K-AKT pathway. Through integrative genomic and functional analyses, the research reveals how S100A10 enhances proliferation, glycolysis, and inhibits apoptosis under hypoxic conditions, highlighting a potential therapeutic target for overcoming GBM chemoresistance.
-
Pentoxifylline: Phosphodiesterase Inhibitor Workflows & Best
2026-06-14
Pentoxifylline delivers robust, data-driven inhibition of inflammatory pathways and cytokine production in both cellular and animal models. Discover advanced workflows, troubleshooting strategies, and practical insights that leverage APExBIO’s Pentoxifylline for high-impact immunomodulatory research.
-
Cholesterol Impedes Intracellular Trafficking of Lipid Nanop
2026-06-13
This study reveals that elevated cholesterol in lipid nanoparticles (LNPs) disrupts their intracellular trafficking, leading to reduced delivery efficiency of nucleic acid cargos. The work introduces high-resolution tracking of LNP/nucleic acid complexes, clarifying the specific role of LNP composition in endosomal escape and offering actionable insights for nucleic acid delivery system design.
-
HyperPFU™ high-fidelity DNA polymerase: Technical PCR Guidan
2026-06-12
HyperPFU™ high-fidelity DNA polymerase enables accurate PCR amplification of long or GC-rich DNA sequences where standard enzymes often fail. It is specifically suited for workflows that require blunt-ended, high-fidelity products, such as cloning and high-throughput sequencing, but should not be used if 3'-A overhangs or sticky ends are required.
-
Caspase-3 Colorimetric Assay Kit: Reliable Apoptosis Detecti
2026-06-12
This authoritative article guides biomedical researchers through practical laboratory scenarios where the Caspase-3 Colorimetric Assay Kit (SKU K2008) delivers reliable, reproducible measurement of DEVD-dependent caspase-3 activity. By addressing protocol optimization, data interpretation, and product selection, it highlights the kit's role in enhancing apoptosis assay outcomes and advancing mechanistic research.
-
Pyridostigmine Attenuates Placental Necroptosis in Preeclamp
2026-06-11
The referenced study demonstrates that pyridostigmine suppresses placental necroptosis and reduces preeclampsia-like symptoms in rats by enhancing non-neuronal cholinergic signaling via α7 nicotinic acetylcholine receptors. These findings highlight the therapeutic potential of modulating nicotinic receptor activity to manage placental ischemia-driven complications.
-
Berberine Targets RXRα/PPARγ/NEDD4 to Suppress SASP in Ather
2026-06-11
The reference study uncovers how berberine mitigates senescence-associated secretory phenotype (SASP) inflammation in atherosclerosis by modulating the RXRα/PPARγ/NEDD4 signaling axis. This mechanistic insight clarifies berberine’s anti-inflammatory effects and provides new directions for targeting vascular aging in translational research.
-
RAB31 Regulates an ESCRT-Independent Exosome Biogenesis Path
2026-06-10
Wei et al. identify RAB31 as a central regulator of an ESCRT-independent pathway for exosome formation, revealing dual roles in intraluminal vesicle (ILV) generation and prevention of MVE degradation. These findings clarify key molecular mechanisms underlying exosome biogenesis and present new directions for investigating protein sorting and secretion.
-
Boosting Assay Reproducibility with Influenza Hemagglutinin
2026-06-10
This article addresses practical laboratory challenges in protein detection and purification, showing how the Influenza Hemagglutinin (HA) Peptide (SKU A6004) enhances reproducibility, workflow safety, and data reliability. Drawing on recent research and product-specific evidence, we guide life science professionals in optimizing immunoprecipitation and protein-protein interaction studies using high-purity HA tag peptides.
-
CBD Attenuates Orofacial Pain via Endocannabinoid and Seroto
2026-06-09
This study demonstrates that cannabidiol (CBD) robustly reduces both sensory and affective components of orofacial inflammatory pain in mice. Through a combination of behavioral assays and molecular analyses, the authors establish that CBD acts through coordinated modulation of endocannabinoid and serotonergic systems, highlighting its translational promise for multidimensional pain management.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Practical Research Gu
2026-06-09
The Annexin V-FITC/PI Apoptosis Assay Kit is designed for the rapid, fluorescence-based identification and discrimination of apoptotic and necrotic cells in cultured samples. This kit addresses the need for precise early apoptosis detection via phosphatidylserine externalization and membrane integrity analysis, but is not intended for diagnostic or clinical use.
-
Pentoxifylline: Mechanistic Power and Translational Promise
2026-06-08
Explore the mechanistic depth and translational strategies underpinning Pentoxifylline as a phosphodiesterase inhibitor. This article bridges molecular rationale with advanced workflow guidance, empowering researchers to optimize anti-inflammatory and immunomodulatory protocols for both preclinical models and clinical translation.
-
Bafilomycin C1: Precision V-ATPase Inhibition for Translatio
2026-06-08
This article explores how Bafilomycin C1, a gold-standard vacuolar H+-ATPases inhibitor, empowers translational researchers to dissect acidification-dependent pathways, de-risk phenotypic screening, and advance disease modeling. By integrating mechanistic insight with actionable strategies, we map how Bafilomycin C1 elevates high-content workflows—particularly in iPSC-derived models—beyond conventional approaches, and address the evolving competitive landscape and translational relevance for cancer and cardiac research.
-
Luminescent ATP Cell Viability Assay Kit I: Precision in Cel
2026-06-07
The Luminescent ATP Cell Viability Assay Kit I streamlines sensitive cell viability measurement with fast, robust luciferase luminescence detection—outperforming traditional colorimetric assays. Its unique workflow accelerates cytotoxicity and cell metabolism studies, enabling high-confidence data even at low cell densities.